NEW YORK, Sept. 16, 2016 -- Barrack, Rodos & Bacine is investigating the Board of Directors of Standex International Corp. (“Standex” or the “Company”) for possible violations of securities laws and Delaware law relating to the Proxy Statement the Company filed concerning the upcoming annual shareholder meeting to be held on October 27, 2016.
The Proxy Statement filed by Standex with the U.S. Securities and Exchange Commission on September 9, 2016 recommends that Standex shareholders vote to approve five Company proposals. Barrack, Rodos & Bacine’s investigation of these Company proposals indicates that they may contain misleading information that will inhibit a meaningful stockholder vote.
Holders of Standex stock are encouraged to contact Michael Toomey of Barrack Rodos & Bacine, at the following toll-free number: 877-386-3304, or via e-mail to [email protected].
Barrack Rodos & Bacine has more than three decades of experience prosecuting securities and corporation law actions, and has achieved some of the largest recoveries in the history of such litigation.
Michael Toomey 877-386-3304 [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



